PDI counts big hit on contract loss
PDI says it will take a $65 million to $70 million hit on AstraZeneca's decision to terminate its biggest sales and marketing contract. PDI says the decision will affect about 800 field reps. PDI's president Steven K. Budd stated, "We are disappointed by AstraZeneca's decision. We have worked with AstraZeneca for over twelve years and look forward to creating future business opportunities with them. We are vigorously exploring potential opportunities to re-deploy these high performing sales teams."
- here's the release for more information
Comments